Healthtech startup CureBay raises around ₹100 crore in a pre-Series C round as it seeks to scale a network of rural clinics and expand its AI-enabled screening offerings. The reported funding amount is cited as roughly ₹100 crore (about $10.6 million in one report).

Different outlets frame the story around different priorities within the same announcement. Inc42 emphasises the company’s plan to enhance its AI screening products alongside the growth of its clinic network. The Economic Times also reports the ₹100 crore figure, focusing on the fundraising aspect of CureBay’s next stage of development without adding substantially different details in the provided summary.

Overall, the coverage agrees that the company is using the new capital to grow rural healthcare access and to strengthen its AI-driven screening services, with the main variation being which element—funding or product expansion—each outlet leads with.